OneOme named “Best Overall Genomics Company” in 2019 MedTech Breakthrough Awards
June 20, 2019 - Minneapolis, MN - OneOme, a leading provider of pharmacogenomics solutions, today announced it won a MedTech Breakthrough Award in the category of Best Overall Genomics Company.
The MedTech Breakthrough Awards recognize innovative leaders in healthcare technology and encompass a broad range of categories. This year, thousands of nominations from around the world were evaluated by an independent panel of experts from the MedTech industry.
“Being named Best Overall Genomics Company by the MedTech Breakthrough Awards is a huge honor,” said OneOme CEO Paul Owen. “Our team is committed to providing the highest quality, evidence-based pharmacogenomics testing and technology. This recognition demonstrates the value we bring to the healthcare industry and validates our philosophy of putting scientific rigor and clinical utility at the heart of everything we do.”
For a full list of 2019 winners, visit https://medtechbreakthrough.com/2019-winners/.
OneOme was co-founded with Mayo Clinic to bring pharmacogenomics into routine clinical care. OneOme is a privately held company backed by early-stage venture firm Invenshure, LLC, and Mayo Clinic.
Editor’s Note: Mayo Clinic has financial investment in the technology referenced in this news release. The revenue that Mayo Clinic will receive is used to support its not-for-profit mission in patient care, education and research.